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Ia antigens on lymphoid cells function as informational molecules that facilitate 
genetically regulated immune responses and cell-to-cell communication (1-4). In 
mice,  two loci within  the  murine  major histocompatibility  complex (H-2),  I-A 
and  I-E,  encode  four polypeptides,  with  molecular  weights of 34,000  daltons 
(the a  chain) and 29,000 daitons,  (the/3 chain) which associate into the hetero- 
dimers  A,Aa and  E~Ea (5).  Over  40  murine  haplotypes are  known  to exist at 
these loci, and further polymorphism probably exists among wild mice popula- 
tions (6). Most of the functional attributes of Ia antigens are due to this genetic 
polymorphism:  Strains  that differ in  their  Ia structure,  predominantly  f3 chain 
variations, differ in their capacity for some immune responses and are mutually 
reactive in MLR. 
The analogous genetic system in  man,  HLA, appears  to be somewhat more 
complicated  than  the  murine  counterpart.  The  HLA-D  locus  was  originally 
defined as the genetic region causing stimulation in MLR (MLR-S) (7). Human 
Ia antigens  map to the  HLA-D region  (8).  These appear to be encoded by at 
least three distinct loci, DR, DS (or DC), and SB, each with its distinct a  and 
chains.  The DRa chain  is structurally analogous to the murine  I-Ea chain,  and 
the  DC/DSa chain  is  structurally  analogous  to the  murine  I-An  chain  (9-1 1). 
The relationship between HLA-D or MLR-S, and the human  "Ia-like" antigens 
remains largely unknown.  Within  the DR4 haplotype, analysis by MLR has led 
to  the  description  of several distinct  HLA-D antigens,  including  Dw4,  Dwl0, 
LD"40", LD"DYT", LD"KT2", and LD"TAS" (12,  13). 
Among particular  HLA specificities associated with prevalent diseases, HLA- 
DR4 has attracted much interest. This antigen is found to be more frequent in 
patients  with adult rheumatoid  arthritis,  insulin-dependent  diabetes, and some 
forms  of juvenile  rheumatoid  arthritis,  than  in  the  general  population.  The 
strength of these associations varies in different racial groups, raising the question 
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of heterogeneity within the clinical spectrum of disease or within the associated 
genetic factors. Groner et al. (14) have utilized two-dimensional polyacrylamide 
gel electrophoresis (PAGE) to demonstrate  molecular heterogeneity within  the 
HLA-DR4 haplotype (14). We have recently described a  similar study in which 
six distinct DR/3 chain patterns were identified among  17 B-lymphoblastoid cell 
lines derived from donors of DR4-associated HLA-D homozygous typing cells 
(HTC) analyzed by two-dimensional PAGE (12). When DR/3 chains representa- 
tive of different HLA-D clusters were compared, the patterns correlated precisely 
with the HLA-D phenotype of the HTC donor. Thus, we suggested in agreement 
with  Groner  et  al.  (14)  that  HLA-D  specificities  could  be  accounted  for  by 
structural variations in the DR/3 chain. 
Phenotypic variation  as defined by MLR, however, is likely to represent  the 
composite expression of the entire  repertoire  of human  "Ia-like" antigens,  not 
just the products of the DR/3 locus. Indeed, it is quite surprising that analysis of 
a  single  component  of the  "D-region,"  the  DR/3 chains,  showed such striking 
correlation  with  the  MLR-defined HLA-D antigen  clusters (12,  14).  We have 
now investigated each of the DR4 homozygous cell lines (HCL) in more detail. 
Neuraminidase treatment of immunoprecipitated DR antigens, followed by two- 
dimensional  gel electrophoresis, clarifies the extent to which glycosylation con- 
tributes to DR/3 chain variability. We also report here the existence of structural 
heterogeneity  within  the  DR4 haplotype for the products of a  second human 
"Ia-like" locus HLA-DS (or DC). Based on the observed differences for DR and 
DS ~ chains five distinct DR4 haplotypes are defined. This analysis may provide 
some insight into the diversity of genetic factors associated with disease. 
Materials and Methods 
Homozygous B-Lymphoblastoid Cell Lines.  Lymphoblastoid cell lines from DR4-associated 
HLA-D HTC were established as previously described (12, 15). Briefly, 1-2 X 106 B cells/ 
ml from donors whose iymphocytes have been used as HTC were mixed with an equal 
volume of culture supernatant from the EBV secreting line B95-8, plated into microwell 
tissue culture plates,  and expanded within  15-60 d.  The cell lines used for this  study 
were:  FS and  EM  (Dwl0);  WALK, HA,  PRIESS,  and  ER (Dw4); LS40 and  BIN  40 
(LD"40"); KT3 and  HAS-15 (LD"DYT"); JHa and  SST (LD"DB3");  KT2 and  KT13 
(LD"KT2"); and TAS (LD"TAS"). All cell lines have been described in detail elsewhere 
(12). The HLA-DR phenotype was confirmed as DR4 for each line by standard HLA-DR 
typing procedures (16,  17). 
Monoclonal Anti-Ia Antibodies.  Antibody P4.1, a  murine  monoclonal  IgG~a antibody 
specific for HLA-DR molecules ("monomorphic")  has been described in detail elsewhere 
(12). Antibody SG157 is also specific for a determinant on DR (I-E-like)  molecules as 
shown by amino acid sequence analysis (18). In contrast, antisera  and monoclonal  anti- 
bodies recognizing  "I-A-like" antigens  distinct  from  DR products have been recently 
described (19). Monoclonal antibody SG4~5 recognizes a determinant on DS ("I-A-like") 
antigens  (20). 
Radiolabeling and  Immunoprecipitation.  Cell  labeling  with  ~25I was performed as de- 
scribed previously (12). Briefly, 4 ×  107 cells in 0.5 ml phosphate-buffered saline with 5 
lucose  oxidase,  and  0 7  U  iacto  eroxidase  (Calbiochem-Behring  mM  glucose,  50 #g g  .  p 
Corp., La Jolla, CA) were incubated with 2 mCi Na l~sI (Amersham,  Arlington  Heights, 
IL) for 20 rain at room temperature.  Cells were lysed as previously  described (12) and 
lysates recovered after pre-clearing with washed heat-killed Cowan  1 strain Staphylococcus 
aureus (SaC 1, BRL, Bethesda,  MD). Lysate was incubated overnight with the appropriate 
monoclonal  antibody, precipitated with SaC 1, and washed repetitively. 396  HLA-DR4-ASSOCIATED POLYMORPHISMS 
For sequential immunoprecipitations, lysates were precipitated with the first antibody 
and the resultant supernatants were then re-precipitated with a second antibody. 
Neuraminidase  Treatment of Cells.  Neuraminidase treatment was carried out using the 
procedure of Shackelford et al.  (21).  Briefly, 150 #1 of radiolabeled lysate prepared as 
above was treated with a total of 150 ~1 of neuraminidase (Calbiochem-Behring Corp.) 
over the course of 5 h at 37°C and then immunoprecipitated as described above. 
Two-dimensional Gel Electrophoresis.  Samples were electrophoresed using a modification 
of the O'Farrell system for nonequilibrium electrofocusing (22), followed by 10% poly- 
acrylamide slab gel electrophoresis, as described previously (12, 23). 
Additive gels were performed by mixing lysate samples  of equivalent 1251 cpm imme- 
diately before loading on the first-dimension gel apparatus. 
Direct  comparisons  between  separate  samples  were  made  only on  gels  that  were 
simultaneously prepared and electrophoresed side-by-side on the same apparatus. 
Results 
Identification of  Distinct DR 4-Associated  DR 13 Chain (I-E-like) Variants Correspond- 
ing  to HLA-D.  Two-dimensional gel  electrophoresis  of immunoprecipitated  13 
chains from homozygous cell lines HA (DR4, Dw4) and EM (DR4,  Dw 10) were 
compared  (Fig.  1).  Precipitations performed  using antibody P4.1,  an  anti-DR 
"monomorphic" monoclonai antibody, showed marked differences in electropho- 
retic  mobility between  Dw4  and  Dwl0  DR  /3 chains.  Most,  if not all,  of the 
charge heterogeneity within each immunoprecipitated glycoprotein appeared to 
be due to post-translational sialylation of the oligosaccharide component of the 
[3 chain, since treatment with neuraminidase greatly simplified the electrophoretic 
pattern. In each case, acidic spots disappeared while the most basic spots increased 
in intensity. 
Similar  electrophoretic  profiles  of  immunoprecipitated  /3  chains  following 
neuraminidase treatment were obtained for all 15 DR4-associated HLA-D homo- 
zygous cell lines listed in Table I. Gels from some of these are shown in Fig. 2, 
along with "additive" gels, in which immunoprecipitates from two cell lines were 
mixed and co-electrophoresed in order to clarify the relationship between similar, 
FIGURE  1.  Two-dimensional  polyacrylamide  gel electrophoresis  of immunoprecipitated DR 
"Ia-like" molecules from HCL EM and HA. Autoradiograms shown display the "Ia-like" /3 
chain, oriented with anode (pH 5) on the right, cathode (pH 8.5) on the left, and with higher 
Mr at the top and lower Mr at the bottom. Panels  A and C show the precipitates from cell lines 
EM and HA without treatment with neuraminidase,  and panels B and D show the precipitates 
after  neuraminidase digestion. All gels were electrophoresed simultaneously  on the  same 
apparatus to facilitate  direct comparisons. NEPOM  ET  AL. 
TABLE  I 
Class~cation of DR and DS [3 Chains Isolated  from HLA-DR4- 
associated HLA-D Homozygous Typing Cells 
HLA-D  HCL 
Electrophoretic variants 
DR  DS 
Dw 10  FS, EM  DR4m  DS4oI 
Dw4  WALK, HA, PRIESS,  DR4az~  DS4~ 
ER 
LD't40  "  BIN40, LS40  DR4tnb  DS4~ 
LD"DYT"  KT3, HAS-15  DR4as  DS4~ 
LD"TAS"  TAS  DR4ca  DS4~3 
LD°DB3 "  JHa, SST  DR4a5  DS4~ 
LD"KT2"  KT2, KT13  DR4o5  DS4xs 
The sources and derivation of these HCL have been described elsewhere 
(12). DR/3 chains were isolated with antibody P4.1  and DS/3 chains were 
isolated with antibody SG465. Types DR2a and DR2b are electrophoret- 
ically distinct before, but not after, neuraminidase. 
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FIGURE 2.  Two-dimensional polyacrylamide gel patterns of neuraminidase-treated immu- 
noprecipitates from  DR4  HCL  from  different HLA-D clusters. Shown  in panels A-F are 
profiles of the/3 chain immunoprecipitates obtained from one representative cell line of each 
of the known DR4-associated HLA-D clusters, except for the Dwl0 cluster (The Dwl0/3 chain 
pattern is shown in Fig. 1). Shown in panels G-L are profiles from "mixing" gels in which two 
separate immunoprecipitates were combined before electrophoresis in order to discern subtle 
differences in electrophoretic mobility between samples.  Multiple samples from each HLA-D 
cluster were analyzed, and in the cases where the observed gel patterns from HCL within the 
same cluster were identical, only one representative gel is shown. 
but nonoverlapping,  spots.  All gels shown  were electrophoresed  simultaneously 
on the same apparatus, to minimize inter-sample variation. The  examples shown 
in Fig. 2  illustrate the differences found between  DR/3 chain polypeptides from 
different  HCL.  Thus,  neuraminidase-treated  DR  antigens  from  lines  KT3 
(LD"DYT")  and BIN 40 (LD"40")  both gave a  pattern consisting of a  dominant 
basic spot with a  faint, slightly more acidic spot (possibly representing incomplete 398  HLA-DR4-ASSOCIATED  POLYMORPHISMS 
sialic acid removal).  When aliquots of the two precipitates were mixed and co- 
electrophoresed (panel G) three distinct spots were seen, indicating that the KT3 
major spot is more basic than  the  BIN  40 major spot. A  similar situation  was 
observed when the gel patterns for cell lines SST (LD"DB3") and WALK (Dw4) 
were compared. In this case, each neuraminidase-treated  precipitate contained a 
major basic spot and a  faint,  slightly more acidic spot, but the "combined"  gel 
indicates that  the major spot from WALK was more basic than  the SST major 
spot (panel I). An additive gel comparing WALK and BIN 40 in panel H indicated 
that these two profiles were identical, since the same pattern was observed in the 
"combined"  gel  as  in  the  gels  for  each  cell  line  studied  alone.  Additional 
comparisons of cell lines TAS (LD"TAS") and KT2 (LDI'KT2 ") with each other 
and with cell lines BIN 40 (LD"40") and SST (LD"DB3") are shown in panels 
J-L and  indicate  that  the SST and  KT2  profiles are identical.  The profile for 
TAS was similar to that of SST and KT2, but had an additional faint basic spot 
that migrated slightly more anodally than the major BIN 40 spot. In additional 
immunoprecipitates (not shown), cell line EM (Dw 10) was identical to FS (Dw 10), 
HA  (Dw4)  and  LS40  (LD"40")  were  identical  to  WALK  (Dw4),  and  JHa 
(LD"DB3") and KTI 3 (LDHKT2  ") were identical to KT2 (LDUKT2"). 
In  all,  we observed five distinct  gel patterns  for the  DR4 /3 chain  following 
neuraminidase  treatment.  The pattern  from cell lines FS and EM was markedly 
different from all the others, suggesting that the Dwl0 cluster expresses a DR/3 
chain only distantly related to the DR/3 chain of the other DR4-associated HLA- 
D  clusters.  The  differences  between  the  other  DR4  HCL,  although  not  as 
dramatic,  were still  distinct,  and correlated in a  consistent way with the  MLR- 
defined D antigen of each HCL. DR/3 chains from HCL of the LD"DYT" and 
LDI'TAS "  clusters  had  unique,  consistent  profiles;  those  from  HCL  of  the 
LD"DB3" and LD"KT2" clusters were identical to each other, but distinct from 
all the other DR4 HCL; those from HCL of the Dw4 and LD"40" clusters were 
identical to each other, but distinct from all the others.  Neuraminidase-treated 
DR chains from these latter four clusters (LD"DYT", LDUTAS", LD"KT2", and 
Dw4) gave gel patterns that differed from each other in only one or two charge 
units  per  molecule.  Such  small  differences probably reflect  minor  amino  acid 
variations, and suggest close evolutionary homology. Since these findings corre- 
lated in a consistent way with MLR reactivity, the differences seen for the DR/3 
chains  may  well  be sufficient  to  explain  the  polymorphism  based on  HLA-D 
typing. 
No  difference  was  found  between  the  DR  /3  chain  from  LD"DB3"  and 
LD"KT2".  This  is consistent  with  our previous report  that  gel patterns  from 
these cells before neuraminidase treatment were identical (12). These two HLA- 
D  clusters  were  originally  defined  in  different  ethnic  populations,  but  more 
recent data from a direct comparative study of the two has suggested that "DB3 # 
and "KT2" may in fact be identical (13). 
The  Dw4 and  LD"40"  comparison  is  more intriguing.  We have  previously 
reported  that  the  DR  /3  chain  profiles  from  these  two  D  clusters  differ  in 
electrophoretic mobility (12). Before neuraminidase treatment, the three/3 chain 
spots present in the LD"40" profile were identical to three of the/3 chain spots 
in  the  Dw4  profile,  but  two  additional  spots  were  seen  in  the  Dw4  profile. NEPOM  ET  AL.  399 
FIGURE 3.  Sequential  immunoprecipitation and two-dimensional gel electrophoresis  of DR4 
"Ia-like" antigens using monoclonal antibodies P4.1 and 8G465. Cell line HA(DR4,Dw4)  was 
radiolabeled and a lysate  prepared as before. Immunoprecipitates using either antibodies  P4.1 
(anti-DR), SG157 (anti-DR), or SG465 (anti-DC/DS) were then used to obtain the gel patterns 
shown in the top panels. Lysates  that had been precipitated with P4.1, and therefore ~cleared" 
of DR molecules, were then re-precipitated with each of the same three antibodies. The 
resultant gel patterns from these sequential immunoprecipitations are shown in the bottom 
three panels. 
Following  neuraminidase  treatment  the  DR /3  chain  profiles  of the  Dw4  and 
LD"40" antigens were indistinguishable. Thus, the primary polypeptides of these 
two DR chains appear to be identical and the variation observed between Dw4 
and LD40 appears to be due to posttranslational changes in the number of sialic 
acid residues. 
Identification  of Distinct  DR4-Associated  DS  /3  Chain  (I-A-like)  Variants.  The 
relative contributions of different human "Ia-like" antigens to immune function 
is not known.  In the mouse, strains  that are identical at one locus, such as I-E, 
but different at the other,  I-A, are mutually reactive in MLR. Assuming that a 
parallel  situation  exists  in  man,  the  composite array  of all  expressed  "Ia-like" 
antigens,  rather  than  solely the products of the DR (I-E like) locus, is likely to 
cause  stimulation  in  MLR.  To  investigate  this  we  analyzed  electrophoretic 
patterns  of  /3  chains  immunoprecipitated  from  HCL  HA  (DR4,Dw4)  using 
antibodies  P4.1,  SG465,  and  SG157  (Fig.  3).  Electrophoretic  profiles  of the 
immunoprecipitated "Ia-like" antigens (upper panels) were very similar for each 
of the three antibodies, but important differences were revealed by a sequential 
immunoprecipitation  procedure:  Cell lysates containing  "Ia-like" antigens  were 
first immunoprecipitated with antibody P4.1 to remove DR molecules, and were 
then re-precipitated  with either antibody P4.1, SG157, or SG465. As shown in 
the lower panels of Fig.  3, this procedure removed, as expected,  DR antigens 
reactive  with  antibodies  P4.1  or  SG157,  but  left  the  "Ia-like"  DS  molecules 
precipitated  by  antibody  SG465.  This  result  is  consistent  with  the  findings 
recently published by Goyert et al. (20). 
Immunoprecipitates from HCL representing each of the DR4-associated HLA- 
D  antigen  clusters  were  then  analyzed  using  antibody  SG465.  Radiolabeled 
lysates from  each  HCL  were  immunoprecipitated  first  with antibody  P4.1  to 
remove DR molecules, and then with antibody SG465, to identify DS molecules. 
Several electrophoretic DS/3 chain variants were identified among the cell lines 
analyzed.  These are shown in Fig.  4. The profiles of HCL FS and EM (Dwl 0) 
were identical  with each  other,  but were different  from the profiles obtained 
from the other DR4 HCL. DS/3 chain profiles from HCL TAS (LD"TASP'), SST 400  HLA-DR4-ASSOC1ATED  POLYMORPHISMS 
FIGURE 4.  Two-dimensional gel electrophoresis of DC/DS "Ia-like" non-DR molecules from 
DR4 HCL. Radiolabeled lysates from each of the DR4 HCL shown were prepared as before, 
and first precipitated with antibody P4.1 to remove DR "Ia-like molecules". These same lysates 
were then immunoprecipitated  using antibody SG465, an anti-DC/DS monoclonal antibody, 
followed by electrophoresis and autoradiography. All gel profiles are oriented the same as for 
the  DR gels in previous figures; all gels were simultaneously electrophoresed on the same 
apparatus to facilitate comparisons. 
(LD"DB3"), and KT2 (LD"KT2") were identical, and migrated more cathodally 
than the FS and EM molecules. The DS 13 chains obtained from WALK (Dw4), 
BIN40 (LD"40"), and KT3 (LD"DYT"), were identical to each other. The DS 
/3 chains from this latter group were more basic than those of the other groups 
and appeared  to  correspond to  the previously published  description of DR4- 
associated °DS" molecules obtained from cell line GM3103 (°WT51") (20). 
Discussion 
We demonstrate, using two-dimensional PAGE, distinct polymorphic/3 chains 
corresponding to both DR and DS gene products within DR4 homozygous cell 
lines. Five distinct polypeptides corresponding to DR4 products and three distinct 
polypeptides corresponding to  DC/DS4  products were identified. Thus,  there 
are at least five different haplotypes associated with the HLA-DR4 specificity, as 
defined by standard typing using alloantisera. Since the observed DR/3 chain gel 
patterns correlate with the  HLA-D  specificity identified by cluster analysis of 
MLR, it is apparent that the DR4 specificity is supertypic to "Ia-like" molecules 
of several D clusters. In other words, HLA-DR4 is a public serologic specificity FI6URE  5. 
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A "family tree" of DR4-associated HCL. 
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shared by different ~Ia-like"  molecules that are present on at least five different 
HLA haplotypes. 
Comparison  of gel patterns suggests several other observations:  First,  within 
the  DR4 haplotype, there appears to be less heterogeneity for DS products, as 
compared with  DR, since we can  identify five different  DR/3 chains and  only 
three  DS  /3 chain  patterns  among  the  HCL  studied.  Second,  the  DS /3  chain 
patterns do not consistently correlate with the known intra-DR4 differences that 
account for reactivity in MLR. Thus,  variation for DR/3 but not DS 3 appears 
to be a more consistent marker for HLA-D. Third,  the similarity between DS/3 
chains from different DR4 HCL suggests a close relationship among certain cells 
with different D haplotypes and different DR molecules. Thus,  the DS/3 chains 
isolated from WALK, BIN40, and KT3 were indistinguishable,  suggesting that 
the LD"DYT" cluster may be closer structurally to the Dw4 and LD"40" clusters 
than  to  other  DR4  clusters.  Similarly,  the  DS  /3  chain  expressed  by TAS  is 
identical  to that on SST and KT2, and suggests that  LD"TAS" may be evolu- 
tionarily closer to the LD"KT2" and LD"DB3 r' clusters than to Dw4, Dwl0, or 
LD'~40  ". 
In several respects, the data from the DS immunoprecipitations reinforce our 
previous  conclusions  based on  the  neuraminidase-treated  DR immunoprecipi- 
tates described above. That is, the Dw 10 HCL FS and EM are markedly different 
from all  other  DR4 HCL for both  DR/3 and  DS /3, indicating  that  the  Dwl0 
cluster has little in common with other DR4 clusters. Also, the Dw4 HCL WALK 
and  the  LD"40"  HCL  BIN40  have  identical  DS  /3  chains,  indicating  a  close 
relationship  consistent with their  similarity  following neuraminidase  treatment 
of DR  molecules.  Finally,  the  DS /3 chains  of HCL  LD"DB3" and  LD"KT2 t' 
were indistinguishable,  as were their DR/3 molecules. 
From  these data,  it  is clear that  DR4 is not a  single  haplotype.  Distinct and 
consistent structural variations exist for the/3 chains of two loci, DR and DS. It 
is  currently  not  known  whether  the  serologically  defined  DR4  specificity  is 
carried by molecules encoded in the DR locus, the DS locus, both or neither.  A 
composite diagram summarizing the relatedness of the different DR4-associated 
HLA-D clusters is illustrated in Fig. 5. The relationships implied by the "family 
tree" are meant to represent levels of structural  similarity and not genetic map 
distance or a precise evolutionary scale. Branch point a separates Dwl0 from the 
other DR4-associated D-clusters based on the identification of unique DR/3 and 
DS /3 chains  (DR4al,  DS481)  on  the  Dwl0  HCL.  Branch  point  b represents  a 
separation of the remaining  DR4 haplotypes into one of two distinct DS groups. 
Within  each  of these  two,  further  subdivision  is  indicated  at  branch  point  c, 402  HLA-DR4-ASSOCIATED  POLYMORPHISMS 
representing further structural variants of DR 3 following neuraminidase treat- 
ment, and therefore probably reflecting allelic variations in amino acid compo- 
sition of related gene products. Branch point d notes our observation that Dw4 
and  "LD40"  appear  to differ only in their posttranslational  glycosylation and 
thus may determine another distinct haplotype. These data are also summarized 
in Table I. 
In all probability, the finding of considerable heterogeneity within a single DR 
haplotype is not  unique to  DR4.  Our  recent  understanding of the molecular 
complexities of human "Ia-like" genes and polypeptides requires a reassessment 
of existing assumptions. The haplotypes DR 1 through DRw 10 were identified 
by  association  analysis  of  the  reactivity  of selected  alloantisera.  It  has  been 
apparent for some time, however, that more than  10 human D/DR haplotypes 
exist,  since multiple distinct D  antigens have been found to be associated not 
only with DR4 but also with DR2, DRw6, DR7, and DRwS, indicating that HLA- 
DR is supertypic to HLA-D (13, 24-36). Gel analysis of "Ia-like" molecules from 
the  DR2-associated  HLA-D  antigens  Dw2  and  Dwl2  (T.  Sasazuki,  personal 
communication) has reportedly shown some variations similar to those described 
for DR4 (12,  14). 
The demonstration of heterogeneity within a group of haplotypes serologically 
defined as equivalent, e.g., DR4, provides a significant insight into the complexity 
of human  "Ia-like" antigens.  Ia structural  polymorphism contributes a  critical 
determinant  controlling  the  recognition of antigen  by  cooperating lymphoid 
cells. Thus, diversity of Ia as shown here not only accounts for patterns of T  cell 
reactivity in MLR, but may also account for some of the polymorphic features 
fundamental to "Ia-regulated" immune responses and to D/DR-associated disease 
susceptibility. Indeed, it is possible that some disease-associated genetic markers 
will be found on unique products of individual loci, not as a  public serologic 
specificity defined by conventional typing reagents. 
Summary 
Among  DR4-associated  HLA-D  antigens,  distinct  and  consistent  structural 
variations were found for the products of two human "Ia-like" loci, DR and DS. 
Analysis of neuraminidase-treated immunoprecipitated DR molecules from  15 
HLA-DR4-associated  HLA-D homozygous B-lymphoblastoid cell lines by two- 
dimensional  polyacrylamide  gel  electrophoresis  identifed  five  distinct  DR  3 
chains. In addition, gel analysis of immunoprecipitated DS molecules identified 
three distinct DS 3 chains. Altogether, five distinct DR4 haplotypes were defined 
according to the observed structural diversity of the DR and DS 3 chains. These 
gene products presumably contribute the dominant polymorphisms recognized 
by T  cells in mixed lymphocyte reaction (MLR). Thus, these studies indicate that 
the  serologic specificity known as  HLA-DR4  is not a  single haplotype, but a 
determinant present on products of individual loci arrayed into distinctly differ- 
ent haplotypes. These findings suggest that distinct products of individual loci, 
rather  than  conventional  HLA  specificities defined  by alloimmune sera,  may 
represent the genetic markers relevant to HLA-D/DR associated diseases. 
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